Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 12.93 B8.57 B28.25 B10.24 B9.99 B 57.04 B Research & development ————— — Operating income 0-228.7 M-272.74 M-685.34 M-407.04 M -1.59 B Non-Operating Income, Total 90.28 M-124.23 M957 K158 K704 K -122.41 M Interest expense, net of interest capitalized 14.07 M14.24 M14.41 M16.52 M17.58 M 62.75 M Non-Operating Income, excl. Interest Expenses 75.53 M-125.15 M000 -125.15 M Unusual income/expense 672 K918 K957 K158 K704 K 2.74 M Pretax income 042.16 M545.2 M-556.5 M-234.56 M -203.69 M Equity in earnings —-607.42 M-1.23 B-22.29 M-41.63 M -1.9 B Taxes 011.47 M40.15 M-74.83 M-18.25 M -41.46 M Non-controlling/minority interest -185.49 M16.19 M——-98.94 M — After tax other income/expense —210 K-1.45 M310 K-996 K -1.92 M Net income before discontinued operations 030.69 M505.06 M-481.67 M-216.31 M -162.23 M Discontinued operations ————— — Net income 030.69 M505.06 M-481.67 M-216.31 M -162.23 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -295.43 M30.69 M223.16 M-365.76 M-191.1 M -303.01 M Basic earnings per share (Basic EPS) -0.80.11.19-1.02-0.48 -0.21 Diluted earnings per share (Diluted EPS) -0.840.082.28-1.31-0.55 0.49 Average basic shares outstanding —135.53 M174.71 M159.2 M192.07 M — Diluted shares outstanding -593.18 M135.53 M221.46 M366.48 M390.48 M — EBITDA 12.61 M-221.24 M-265.34 M-678.74 M-401.2 M -1.57 B EBIT 0-228.7 M-272.74 M-13.66 B-407.04 M -14.57 B Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 12.61 M7.46 M7.4 M6.6 M5.84 M 27.29 M